Background: Cervical and breast cancers are the leading malignancies in females in India. Cancer cervix is preventable and treatable if detected at premalignant stage. Pap smear is a recommended screening method for cancer cervix and its precursors. Pap smear screening in antenatal period presents an opportunity to screen for premalignant cervical lesions and genital infections. This study was undertaken to determine the prevalence of abnormal cervical smears and genital infections among antenatal women.Methods: It is a prospective study in which, 200 antenatal mothers at booking visit, were included in the study. Details on their demographic characteristics, obstetric profile, and past history of Pap test were collected. Liquid based cytology was used for the test. The cytological results were reported based on the Bethesda classification system 2001.Results: Among 200 antenatal women 57% were between 21-25 yrs of age and 18% were less than 20 years. 38% of women were less than 20 years of age at the time of beginning of sexual activity. 56% were primi gravida and others were multi gravida. 95.5 % of women were literate. 89% of women were unaware of Pap smear test. Among the 200 Pap smear reports, 23% were normal, 55.5% nonspecific inflammatory changes, 8.5% Candida infection and 13% bacterial vaginosis. None were reported with premalignant changes.Conclusions: In a population where people do not undergo Pap test due to varied reasons, antenatal Pap test not only provides an excellent opportunity to screen and create awareness for further screening, also helps detect genital infections.
Background: The burden of malignancy and deaths due to it are rising worldwide. In women gynaecological malignancies are among the most common cancers. This study was undertaken to study the pattern and relative frequencies of gynaecological malignancies among women admitted in the Department of Gynaecology, at Saveetha Medical College and Hospital, Tamil Nadu.Methods: This is a retrospective observational study done at the department of Saveetha Medical College and Hospital over a period of two years from September 2015 to September 2017. Case records of women admitted in the Department of Gynaecology and diagnosed to have gynaecological malignancy were retrieved from the department of medical records. Information regarding demographic details, site of malignancy, histopathology of malignancy was analysed and expressed as percentages.Results: During the study period 49 cases of gynaecological malignancies were reported. Out of 49 cases, 36 cases were cancer cervix, followed by 7 cases of ovarian malignancy and 6 cases of cancer of uterine corpus. The mean ages of cancer cervix, ovary and corpus uteri were 51.1, 53.3 and 47.2 years respectively. All women were multiparous in the study. One third of women were premenopausal. Women with cancer cervix and corpus uteri commonly presented with irregular bleeding, post-menopausal bleeding and white discharge per vaginum. Ovarian cancers presented commonly with abdominal pain and distension. Squamous cell carcinoma of cervix was the commonest histopathology seen. Adenocarcinoma and epithelial cancer was the commonest histopathology seen in endometrial and ovarian cancer respectively.Conclusions: Cancer cervix was the commonest gynaecological malignancy in the study population followed by ovarian and uterine malignancies.
6121 Background: In 2002, Kansas City Cancer Center (KCCC) performed a quality improvement (QI) project to evaluate how breast cancer patients were being assessed for family history and cancer risk management. A self-administered family history questionnaire was developed to improve the thoroughness of family history collected and education of clinicians was completed to improve the recognition of risk factors based on ASCO guidelines. Methods: Chart audits on 210 women with breast cancer at KCCC, were completed in the second quarter of 2005. All patients were under the age of 65, not undergoing chemotherapy. A risk management tool was developed. Scoring criteria for 2002 was replicated in 2005 as listed in the table . Results: In 2002, 171 pts (89%) had level 1 or 2 family history assessed compared to 207 pts (99%) in 2005, p<0.0001. In 2002, 47% had 3 generations assessed compared to 84% in 2005, p<0.0001. In 2002 and 2005, some risk factor management occurred in both groups, and was equal, 78% and 80% respectively (p=ns). Of those that had risk management 33% had level 1 in 2002 compared to 3% in 2005 (p<0.0001) a 91% reduction in identifying risk without subsequent management. In 2002, 58% had level 2, compared to 71% in 2005 (p=0.02) a 23% improvement in identification & management of risk. In 2002, 9% had level 3 compared to 26% in 2005 (p<0.0001) a 183% improvement in patients with a detailed risk assessment and/or genetic referral. Conclusions: By improving the assessment of family history and education of providers, women with breast cancer are receiving more information to reduce their risk for recurrence and complications. Patients who were identified as high risk for BRCA1 or BRCA2 mutations were referred to either a nurse practitioner or genetic counselor. [Table: see text] No significant financial relationships to disclose.
Labial adhesion is a gynecological condition where adhesion of labia minora occurs in the midline. It is commonly seen in the prepubertal age group, causing parental anxiety, rarely seen in postmenopausal women, and very rarely seen in the reproductive age group. Hypoestrogenism and inflammation are usually considered as a cause of labial adhesion. Many cases present with urinary symptoms leading to misdiagnosis unless a clinical examination is done. Management can be observation, medical, or surgical. Management becomes difficult in case of recurrences. We present a case of a 12-year-old pubertal girl who came to our hospital. She was misdiagnosed and was treated elsewhere as a urinary tract infection.Here she was diagnosed with labial adhesion and was treated for the same. She had recurrent adhesions which were managed appropriately.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.